RocketTickers

Marker Therapeutics Receives FDA Orphan Drug Designation for its

Long
NASDAQ:MRKR   Marker Therapeutics, Inc
MRKR: Marker Therapeutics , Inc.
2020-04-29 16:05:00
Marker Therapeutics Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Acute Myeloid Leukemia